Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 5665-5671, November 1, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawada, N.
Right arrow Articles by Pitot, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawada, N.
Right arrow Articles by Pitot, H. C.

Effects of Tumor-promoting Agents 12-O-Tetradecanoylphorbol-13-acetate and Phenobarbital on DNA Synthesis of Rat Hepatocytes in Primary Culture1

Norimasa Sawada2, Jeffrey L. Staecker and Henry C. Pitot3

McArdle Laboratory for Cancer Research, The Medical School, University of Wisconsin, Madison, Wisconsin 53706

Both 12-O-tetradecanoylphorbol-13-acetate (TPA) and phenobarbital (PB) enhanced hepatocyte DNA synthesis stimulated with epidermal growth factor (EGF) by 60 to 80% in primary culture when measured by the incorporation of [3H]thymidine. This apparent increase was not due to changes in the specific activity of the deoxythymidine triphosphate (dTTP) pool. TPA enhanced DNA synthesis even at relatively high cell densities, but this was not found with the PB treatment. Although both TPA and PB enhanced DNA synthesis significantly, TPA was most effective when added during the late G1 and/or S phase of the hepatocyte cell cycle, whereas PB treatment was least effective in this period. The binding of EGF was transiently down-regulated by TPA, then restored to control values 6 h later, whereas the binding of this factor was significantly increased at both the 12th and 24th h after PB addition. These results suggest that EGF binding to hepatocytes is not correlated with the enhancement of DNA synthesis by TPA or PB and that the down-regulation of EGF binding is not causally related to the enhancement of DNA synthesis by TPA.

1 This work was supported in part by grants CA-07175, CA-09135, and CA-22484 from the National Cancer Institute.

2 Supported by Cancer Research Campaign Grant D (United Kingdom) from the International Union Against Cancer. Present address: Department of Experimental Pathology, Cancer Institute, Kamiikebukuro, Toshima-ku, Tokyo, Japan.

3 To whom requests for reprints should be addressed.

Received 11/14/86. Revised 2/27/87. Revised 7/30/87. Accepted 8/10/87.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
N.J. Hodges, T.C. Orton, A.J. Strain, and J.K. Chipman
Potentiation of epidermal growth factor-induced DNA synthesis in rat hepatocytes by phenobarbitone: possible involvement of oxidative stress and kinase activation
Carcinogenesis, November 1, 2000; 21(11): 2041 - 2047.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G.-H. Lee
Review Article: Paradoxical Effects of Phenobarbital on Mouse Hepatocarcinogenesis
Toxicol Pathol, March 1, 2000; 28(2): 215 - 225.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.